As part of our product development process, we conduct a feasibility study for manufacturing. In August 2021, our manufacturers recommended a few modifications leading us to make additional product design changes.
The design on the left is Version 2.0 with the newest design, Version 3.0, on the right.
We upgraded the device by redesigning the back to make it flatter, increasing comfortability and stability, as well as refitting the circuit board and power source into the front section of the device. This will further reduce the size of OxiWear.
In April 2021, we received our design and utility patents from the USPTO – United States Patent and Trademark Office. The patent numbers are: 10,987,067 and D916,291.
OxiWear received its international patent cooperation treaty (PCT) utility patent approval and is now filing for country specific applications in 14 additional countries, including Canada, Israel, South Korea, and Japan.
The Patent Cooperation Treaty (PCT) assists applicants in seeking patent protection internationally for their inventions, helps patent offices with their patent granting decisions, and facilitates public access to a wealth of technical information relating to those inventions. By filing one international patent application under the PCT, applicants can simultaneously seek protection for an invention in a large number of countries.
After completing the redesign, we submitted for our new design patent through our legal consultant, Cooley, LLP.
This was an exciting and transformational change for OxiWear, but it ultimately led us to another slight delay in production. At this time, our targeted product launch timeframe is July 2022.